Christopher James Sampson : Citation Profile

Are you Christopher James Sampson?

Office of Health Economics

3

H index

0

i10 index

16

Citations

RESEARCH PRODUCTION:

6

Articles

9

Papers

RESEARCH ACTIVITY:

   9 years (2013 - 2022). See details.
   Cites by year: 1
   Journals where Christopher James Sampson has often published
   Relations with other researchers
   Recent citing documents: 7.    Total self citations: 0 (0 %)

EXPERT IN:

   Health
   Publicly Provided Goods
   Welfare Economics

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psa1048
   Updated: 2023-03-02    RAS profile: 2022-10-11    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Lorgelly, Paula (2)

Devlin, Nancy (2)

Garau, Martina (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Christopher James Sampson.

Is cited by:

Shah, Koonal (2)

Lorgelly, Paula (1)

Neri, Margherita (1)

Graf von der Schulenburg, Johann (1)

Devlin, Nancy (1)

Garau, Martina (1)

Cites to:

Brazier, John (4)

Devlin, Nancy (4)

Niessen, Louis (2)

Danzon, Patricia (2)

Frew, Emma (2)

Parkin, David (2)

Newhouse, Joseph (2)

Christensen, Garret (1)

Brouwer, Werner (1)

Riccaboni, Massimo (1)

Belleflamme, Paul (1)

Main data

Where Christopher James Sampson has published?

Journals with more than one article published# docs
PharmacoEconomics - Open2

Working Papers Series with more than one paper published# docs
MPRA Paper / University Library of Munich, Germany3
Briefing / Office of Health Economics2
Research Paper / Office of Health Economics2
Consulting Report / Office of Health Economics2

Recent works citing Christopher James Sampson (2022 and 2021)

YearTitle of citing document
2022The diffusion of robotic surgery: Examining technology use in the English NHS. (2022). Serra-Sastre, Victoria ; McGuire, Alistair ; Pearson, Georgia ; Maynou, Laia. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:4:p:325-336.

Full description at Econpapers || Download paper

2022The diffusion of robotic surgery: examining technology use in the English NHS. (2022). Serra-Sastre, Victoria ; McGuire, Alistair ; Pearson, Georgia ; Maynou, Laia. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:114535.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2022Exploring EQ-5D-Y-3L Experience-Based VAS Values Derived Among Adolescents. (2022). Burstrom, Kristina ; Rolfson, Ola. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-021-00713-w.

Full description at Econpapers || Download paper

2022Categorization and eccentricity of AI risks: a comparative study of the global AI guidelines. (2022). Zhang, Nan ; Jia, Kai. In: Electronic Markets. RePEc:spr:elmark:v:32:y:2022:i:1:d:10.1007_s12525-021-00480-5.

Full description at Econpapers || Download paper

2021The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology Assessment. (2021). Whittal, Amanda ; Nicod, Elena ; Meregaglia, Michela. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:5:d:10.1007_s40271-020-00493-w.

Full description at Econpapers || Download paper

2022A Comparison of PROPr and EQ-5D-5L Value Sets. (2022). Devlin, Nancy ; Viney, Rosalie ; Mulhern, Brendan ; Pan, Tianxin ; Hanmer, Janel ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:3:d:10.1007_s40273-021-01109-3.

Full description at Econpapers || Download paper

Works by Christopher James Sampson:

YearTitleTypeCited
2019How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy In: Briefing.
[Full Text][Citation analysis]		paper1
2021How is Quality of Life Measured for Health Technology Assessments? In: Briefing.
[Full Text][Citation analysis]		paper0
2018Barriers to Uptake of Minimal Access Surgery in the United Kingdom In: Consulting Report.
[Full Text][Citation analysis]		paper2
2018The Impact of New Medicines in the NHS: 70 Years of Innovation In: Consulting Report.
[Full Text][Citation analysis]		paper0
2018R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C In: Research Paper.
[Full Text][Citation analysis]		paper3
2020Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? In: Research Paper.
[Full Text][Citation analysis]		paper2
2013Cost implications of treatment non-completion in a forensic personality disorder service In: MPRA Paper.
[Full Text][Citation analysis]		paper0
2013Happy and healthy: a joint model of health and life satisfaction In: MPRA Paper.
[Full Text][Citation analysis]		paper0
2013The relationship between individual risk and cost-effectiveness in screening interventions In: MPRA Paper.
[Full Text][Citation analysis]		paper0
2021Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al. In: Medical Decision Making.
[Full Text][Citation analysis]		article1
2022Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article0
2013Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2019Transparency in Decision Modelling: What, Why, Who and How? In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2017Model Registration: A Call to Action In: PharmacoEconomics - Open.
[Full Text][Citation analysis]		article4
2022NICE and the EQ-5D-5L: Ten Years Trouble In: PharmacoEconomics - Open.
[Full Text][Citation analysis]		article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated January, 6 2023. Contact: CitEc Team